Ulf Schulze‐Topphoff

2.6k total citations
22 papers, 2.0k citations indexed

About

Ulf Schulze‐Topphoff is a scholar working on Immunology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Ulf Schulze‐Topphoff has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Ulf Schulze‐Topphoff's work include Multiple Sclerosis Research Studies (7 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Ulf Schulze‐Topphoff is often cited by papers focused on Multiple Sclerosis Research Studies (7 papers), Immunotherapy and Immune Responses (7 papers) and T-cell and B-cell Immunology (7 papers). Ulf Schulze‐Topphoff collaborates with scholars based in United States, Germany and Australia. Ulf Schulze‐Topphoff's co-authors include Scott S. Zamvil, Michel Varrin‐Doyer, Collin M. Spencer, Bruce Cree, Raymond A. Sobel, Aparna Shetty, Frauke Zipp, Patricia A. Nelson, Orhan Aktaş and Timour Prozorovski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Ulf Schulze‐Topphoff

22 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulf Schulze‐Topphoff United States 16 814 711 581 293 216 22 2.0k
Elvira Ventura United States 20 778 1.0× 287 0.4× 483 0.8× 245 0.8× 152 0.7× 25 1.6k
Bernadette Kálmán United States 26 483 0.6× 932 1.3× 723 1.2× 279 1.0× 211 1.0× 83 2.0k
Joost Drexhage Netherlands 22 417 0.5× 827 1.2× 472 0.8× 687 2.3× 152 0.7× 27 2.0k
Unsong Oh United States 24 722 0.9× 410 0.6× 293 0.5× 296 1.0× 212 1.0× 46 1.8k
Nazar Mashtalir United States 26 303 0.4× 1.9k 2.7× 445 0.8× 76 0.3× 213 1.0× 33 3.0k
Belinda J. Kaskow United States 11 393 0.5× 496 0.7× 384 0.7× 333 1.1× 131 0.6× 13 1.3k
Man‐Wook Hur South Korea 26 184 0.2× 1.4k 1.9× 121 0.2× 73 0.2× 99 0.5× 77 2.0k
Harald H. Hofstetter Germany 21 964 1.2× 314 0.4× 427 0.7× 244 0.8× 141 0.7× 35 1.7k
Pierre Olivier Couraud France 25 433 0.5× 1000 1.4× 184 0.3× 612 2.1× 106 0.5× 36 2.1k
Steven J. Mullett United States 21 662 0.8× 876 1.2× 61 0.1× 207 0.7× 226 1.0× 37 2.0k

Countries citing papers authored by Ulf Schulze‐Topphoff

Since Specialization
Citations

This map shows the geographic impact of Ulf Schulze‐Topphoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Schulze‐Topphoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Schulze‐Topphoff more than expected).

Fields of papers citing papers by Ulf Schulze‐Topphoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Schulze‐Topphoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Schulze‐Topphoff. The network helps show where Ulf Schulze‐Topphoff may publish in the future.

Co-authorship network of co-authors of Ulf Schulze‐Topphoff

This figure shows the co-authorship network connecting the top 25 collaborators of Ulf Schulze‐Topphoff. A scholar is included among the top collaborators of Ulf Schulze‐Topphoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulf Schulze‐Topphoff. Ulf Schulze‐Topphoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ziemssen, Tjalf, Michael Lang, Stephan Schmidt, et al.. (2022). Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany. Journal of Neurology. 269(6). 3276–3285. 15 indexed citations
2.
Ziemssen, Tjalf, Judith Haas, Luisa Klotz, et al.. (2021). Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients. Frontiers in Neurology. 12. 637107–637107. 4 indexed citations
3.
Ziemssen, Tjalf & Ulf Schulze‐Topphoff. (2021). The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0. Journal of Personalized Medicine. 11(6). 561–561. 4 indexed citations
4.
Ziemssen, Tjalf, Michael Lang, Björn Tackenberg, et al.. (2019). PANGAEA: Effectiveness and safety of fingolimod over 5 years in daily clinical practice (P3.2-086). Neurology. 92(15_supplement). 1 indexed citations
5.
Varrin‐Doyer, Michel, Kara Pekarek, Collin M. Spencer, et al.. (2016). Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression. Neurology Neuroimmunology & Neuroinflammation. 3(5). e272–e272. 28 indexed citations
6.
Onizawa, Michio, Shigeru Oshima, Ulf Schulze‐Topphoff, et al.. (2015). The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis. Nature Immunology. 16(6). 618–627. 229 indexed citations
7.
Kuhla, Angela, et al.. (2015). Liver-specific Fas silencing prevents galactosamine/lipopolysaccharide-induced liver injury. APOPTOSIS. 20(4). 500–511. 6 indexed citations
8.
Molnarfi, Nicolas, Thomas Prod’homme, Ulf Schulze‐Topphoff, et al.. (2015). Glatiramer acetate treatment negatively regulates type I interferon signaling. Neurology Neuroimmunology & Neuroinflammation. 2(6). e179–e179. 14 indexed citations
9.
Varrin‐Doyer, Michel, Scott S. Zamvil, & Ulf Schulze‐Topphoff. (2014). Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis. Experimental Neurology. 262. 66–71. 35 indexed citations
10.
Shetty, Aparna, Michel Varrin‐Doyer, Martin S. Weber, et al.. (2014). Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE. Neurology Neuroimmunology & Neuroinflammation. 1(2). e22–e22. 29 indexed citations
11.
Schulze‐Topphoff, Ulf, Michel Varrin‐Doyer, Kara Pekarek, Robert H. Scannevin, & Scott S. Zamvil. (2014). Dimethyl Fumarate Utilizes Nrf2-Independent and Nrf2-Dependent Pathways For Immune Modulation (S53.006). Neurology. 82(10_supplement). 6 indexed citations
12.
Molnarfi, Nicolas, Ulf Schulze‐Topphoff, Martin S. Weber, et al.. (2013). MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. The Journal of Experimental Medicine. 210(13). 2921–2937. 318 indexed citations
13.
Schulze‐Topphoff, Ulf, Simona Casazza, Michel Varrin‐Doyer, et al.. (2013). Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity. The Journal of Experimental Medicine. 210(7). 1301–1309. 38 indexed citations
14.
Schulze‐Topphoff, Ulf, Aparna Shetty, Michel Varrin‐Doyer, et al.. (2012). Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity. PLoS ONE. 7(3). e33797–e33797. 82 indexed citations
15.
Varrin‐Doyer, Michel, Collin M. Spencer, Ulf Schulze‐Topphoff, et al.. (2012). Aquaporin 4‐specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Annals of Neurology. 72(1). 53–64. 263 indexed citations
16.
Schulze‐Topphoff, Ulf, Alexandre Prat, Timour Prozorovski, et al.. (2009). Activation of kinin receptor B1 limits encephalitogenic T lymphocyte recruitment to the central nervous system. Nature Medicine. 15(7). 788–793. 97 indexed citations
17.
Siffrin, Volker, Alexander U. Brandt, Helena Radbruch, et al.. (2009). Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. Brain. 132(5). 1247–1258. 58 indexed citations
18.
Prozorovski, Timour, Ulf Schulze‐Topphoff, Robert Glumm, et al.. (2008). Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nature Cell Biology. 10(4). 385–394. 380 indexed citations
19.
Hoffmann, Olaf, Josef Priller, Timour Prozorovski, et al.. (2007). TRAIL limits excessive host immune responses in bacterial meningitis. Journal of Clinical Investigation. 117(7). 2004–2013. 59 indexed citations
20.
Schulze‐Topphoff, Ulf, Alexandre Prat, Michael Bäder, Frauke Zipp, & Orhan Aktaş. (2007). Roles of the kallikrein/kinin system in the adaptive immune system. International Immunopharmacology. 8(2). 155–160. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elvira Ventura Breakdown of academic impact, for papers by Bernadette Kálmán Breakdown of academic impact, for papers by Joost Drexhage Breakdown of academic impact, for papers by Unsong Oh Breakdown of academic impact, for papers by Nazar Mashtalir Breakdown of academic impact, for papers by Belinda J. Kaskow Breakdown of academic impact, for papers by Man‐Wook Hur Breakdown of academic impact, for papers by Harald H. Hofstetter Breakdown of academic impact, for papers by Pierre Olivier Couraud Breakdown of academic impact, for papers by Steven J. Mullett
Rankless by CCL
2026